2017•Dermatology TimesRequires access
Less isotretinoin monitoring
John Jesitus
Open publisher page 0 citations
Abstract
The lack of serious laboratory abnormalities in patients on isotretinoin suggests that reduced monitoring may suffice.
John Jesitus
Abstract
The lack of serious laboratory abnormalities in patients on isotretinoin suggests that reduced monitoring may suffice.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The lack of serious laboratory abnormalities in patients on isotretinoin suggests that reduced monitoring may suffice.
Key concepts: Medicine, Isotretinoin, Dermatology, Clinical pharmacology, Acne, Pharmacology